Ram, Z., et al. (1997). Therapy of malignant brain tumors by intratumoral implantation
of retroviral vector-producing cells. Nat. Med. 3: 1354 – 1361.
Trask, T. W., et al. (2000). Phase I study of adenoviral delivery of the HSV-tk gene and
ganciclovir administration in patients with current malignant brain tumors. Mol. Ther.
1: 195 – 203.
Markert, J. M., et al. (2000). Conditionally replicating herpes simplex virus mutant,
G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 7:
867 – 874.
Rampling, R., et al. (2000). Toxicity evaluation of replication-competent herpes simplex
virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene
Ther. 7.
Holland, E. C. (2001). Gliomagenesis: genetic alterations and mouse models. Nat. Rev.
Genet. 2: 120 – 129.
Maraskovsky, E., et al. (1996). Dramatic increase in the numbers of functionally mature
dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations
identified. J. Exp. Med. 184: 1953 – 1962.
Pulendran, B., et al. (1997). Developmental pathways of dendritic cells in vivo: distinct
function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated
mice. J. Immunol. 159: 2222 – 2231.
Serot, J. M., Foliguet, B., Bene, M. C., and Faure, G. C. (1997). Ultrastructural and
immunohistological evidence for dendritic-like cells within human choroid plexus
epithelium. Neuroreport 8: 1995 – 1998.
Lowenstein, P. R. (2002). Dendritic cells and immune responses in the central nervous
system. Trends Immunol. 23: 70.
Kruse, C. A., Molleston, M. C., Parks, E. P., Schiltz, P. M., Kleinschmidt-DeMasters, B. K.,
and Hickey, W. F. (1994). A rat glioma model, CNS-1, with invasive characteristics
similar to those of human gliomas: a comparison to 9L gliosarcoma. J. Neurooncol. 22:
191 – 200.
Dewey, R. A., et al. (1999). Chronic brain inflammation and persistent herpes simplex
virus 1 thymidine kinase expression in survivors of syngeneic glioma treated
by adenovirus-mediated gene therapy: implications for clinical trials. Nat. Med. 5:
1256 – 1263.
Cowsill, C., et al. (2000). Central nervous system toxicity of two adenoviral vectors
encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced
cytotoxicity of a truncated HSV1-TK. Gene Ther. 7: 679 – 685.
Bigliari, A., et al. (2004). Effects of ectopic decorin in modulating intracranial glioma
progression in vivo, in a rat syngeneic model. Mol. Ther. (in press).
Lowenstein, P. R. (2002). Immunology of viral-vector-mediated gene transfer into
the brain: an evolutionary and developmental perspective. Trends Immunol. 23:
23 – 30.
Serafini, B., Columba-Cabezas, S., Di Rosa, F., and Aloisi, F. (2000). Intracerebral
recruitment and maturation of dendritic cells in the onset and progression of
experimental autoimmune encephalomyelitis. Am. J. Pathol. 157: 1991 – 2002.
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., and Aloisi, F. (2004). Detection of
ectopic B-cell follicles with germinal centers in the meninges of patients with secondary
progressive multiple sclerosis. Brain Pathol. 14: 164 – 174.
Aloisi, F., Ria, F., and Adorini, L. (2000). Regulation of T-cell responses by CNS
antigen-presenting cells: different roles for microglia and astrocytes. Immunol. Today
21: 141 – 147.
Fischer, H. G., and Reichmann, G. (2001). Brain dendritic cells and macrophages/
microglia in central nervous system inflammation. J. Immunol. 166: 2717 – 2726.
Fischer, H. G., Bonifas, U., and Reichmann, G. (2000). Phenotype and functions of
brain dendritic cells emerging during chronic infection of mice with Toxoplasma
gondii. J. Immunol. 164: 4826 – 4834.
Suter, T., et al. (2003). The brain as an immune privileged site: dendritic cells of the
central nervous system inhibit T cell activation. Eur. J. Immunol. 33: 2998 – 3006.
Kivisakk, P., et al. (2004). Expression of CCR7 in multiple sclerosis: implications for CNS
immunity. Ann. Neurol. 55: 627 – 638.
Pashenkov, M., Teleshova, N., and Link, H. (2003). Inflammation in the central nervous
system: the role for dendritic cells. Brain Pathol. 13: 23 – 33.
Stevenson, P. G., Austyn, J. M., and Hawke, S. (2002). Uncoupling of virus-induced
inflammation and anti-viral immunity in the brain parenchyma. J. Gen. Virol. 83:
1735 – 1743.
Carson, M. J., Reilly, C. R., Sutcliffe, J. G., and Lo, D. (1999). Disproportionate
recruitment of CD8+T cells into the central nervous system by professional antigenpresenting cells. Am. J. Pathol. 154: 481 – 494.
Matyszak, M. K., and Perry, V. H. (1996). The potential role of dendritic cells in
immune-mediated inflammatory diseases in the central nervous system. Neuroscience
74: 599 – 608.
Sroga, J. M., Jones, T. B., Kigerl, K. A., McGaughy, V. M., and Popovich, P. G. (2003).
Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp.
Neurol. 462: 223 – 240.
Zirger, J. M., et al. (2004). Immune system regulation of transgene expression in the
brain. 2. Differential increase of mRNAs encoding for interferon-regulated, chemokine,
and T-cell genes during either innate acute or chronic systemic adaptive immune
responses to first generation adenoviral viral vectors. Mol. Ther. 9(Suppl. 1): 1019.
Barcia, C., et al. (2004). Immune system regulation of transgene expression in the
